The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management

• Status: Not yet recruiting
• Trial end date: 2022-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) from Hemp Oil in patients with Chronic pain, anxiety and insomnia. It is believed that CBD will improve pain anxiety and sleep quality and reduce opioid use. The study will last a total of 4 weeks and involve onsite visits in addition to weekly pain assessments.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Advanced Pain and Rehab Specialists
• Collaborator: Hemp synergistics

Criteria

Inclusion criteria:

• Patients with pain >3 months who are using oral analgesic including narcotics and or physical therapy to reduce pain.

• Patient provides informed consent

• Older than 21 years old,

• Previously have used CBD or marijuana

• Speaks English

Exclusion criteria:

• Patients who are receiving interventional pain procedures or surgery within 30 days

• for their pain

• Patients who have had pain <3 months

• Presence of serious medical illness

• Pregnant females

• Use of P450 modifying medications.